lorazepam and 4-amino-8-(2,5-dimethoxyphenyl)-n-propylcinnoline-3-carboxamide

lorazepam has been researched along with 4-amino-8-(2,5-dimethoxyphenyl)-n-propylcinnoline-3-carboxamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, X; Cross, AJ; de Kam, ML; Hay, JL; Jacobs, GE; Lappalainen, J; Nahon, KJ; Te Beek, ET; van Gerven, JM	1

Trials

1 trial(s) available for lorazepam and 4-amino-8-(2,5-dimethoxyphenyl)-n-propylcinnoline-3-carboxamide

Article	Year
The effects of the nonselective benzodiazepine lorazepam and the α2 /α3 subunit-selective GABAA receptor modulators AZD7325 and AZD6280 on plasma prolactin levels. Clinical pharmacology in drug development, 2015, Volume: 4, Issue:2 Topics: Adolescent; Adult; Biomarkers; Cross-Over Studies; Double-Blind Method; GABA Modulators; Germany; Healthy Volunteers; Heterocyclic Compounds, 2-Ring; Humans; Lorazepam; Male; Middle Aged; Prolactin; Receptors, GABA-A; Young Adult	2015

Article

Year

The effects of the nonselective benzodiazepine lorazepam and the α2 /α3 subunit-selective GABAA receptor modulators AZD7325 and AZD6280 on plasma prolactin levels.

Clinical pharmacology in drug development, 2015, Volume: 4, Issue:2

Topics: Adolescent; Adult; Biomarkers; Cross-Over Studies; Double-Blind Method; GABA Modulators; Germany; Healthy Volunteers; Heterocyclic Compounds, 2-Ring; Humans; Lorazepam; Male; Middle Aged; Prolactin; Receptors, GABA-A; Young Adult

2015